A Study of AMC6156 in People With Sarcopenia

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Sarcopenia in Elderly, Sarcopenia

In brief

This clinical trial aims to find out whether AMC6156 can improve physical function and is safe in older adults with sarcopenia. Participants will take AMC6156 or a placebo daily for 12 weeks, and their movement, strength, and safety will be regularly monitored through tests and checkups.

Key facts

Study ID
NCT07072195
Run by
Animuscure Inc.
People needed
80
Starts
2025-07-01
Expected to finish
2027-02-15
Last updated by the study team
2026-08-03

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.